Fundraising Fox

Neurolieve Biosciences

Founded 2024 · 2 employees on LinkedIn · 2 known investors

Neurolieve is a life-science company developing therapeutics for neuropathic and chronic pain, with expertise in neuroscience, clinical pain medicine and drug development. Its lead program, NLV-01, is built on protein-engineering technology contributed by co-founding partner LifeArc.

Investors · 2

Frequently asked questions

What does Neurolieve Biosciences do?
Neurolieve is a life-science company developing therapeutics for neuropathic and chronic pain, with expertise in neuroscience, clinical pain medicine and drug development. Its lead program, NLV-01, is built on protein-engineering technology contributed by co-founding partner LifeArc.
Who are Neurolieve Biosciences's investors?
Neurolieve Biosciences's investors include NLC, Innovate UK.